Breakthrough Study Links Rare Genetic Mutation to Schizophrenia, Reveals Impact on Brain Function

In a groundbreaking study published on February 23, 2025, researchers have identified a rare genetic mutation associated with schizophrenia that significantly alters brain function. The discovery was made after studying two patients diagnosed with the disorder.

The mutation in question leads to elevated levels of glycine decarboxylase (GLDC), an enzyme responsible for breaking down glycine. Glycine is crucial for the activation of NMDA receptors, which play a key role in neural communication and memory formation. By degrading glycine, the mutation results in reduced activation of these receptors, potentially contributing to the cognitive and behavioral symptoms observed in schizophrenia.

To investigate the effects of this mutation further, scientists introduced it into mice models. The results showed an increase in behaviors typically related to schizophrenia, thereby providing additional evidence linking GLDC levels and receptor activity to the disorder.

This finding opens new avenues for understanding the biological underpinnings of schizophrenia and could lead to more targeted therapies that address specific genetic factors involved in the disease. 

Date: 23 February, 2025

Newsflash | Powered by GeneOnline AI

Author

Mark Chiang